메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한정신약물학회 Clinical Psychopharmacology and Neuroscience Clinical Psychopharmacology and Neuroscience 제6권 제2호
발행연도
2008.1
수록면
49 - 56 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Nitric oxide (NO) is an important molecule, and was named“molecule of the year” by the journal Science in 1992. NO plays a pivotal role in physiological and pathological processes in the brain. There is no doubt that excitability and neurotransmitter release are modulated by NO in the brain. The effects of NO are mediated primarily by cGMP and glutamate. The NO-cGMP system is required for activity-dependent synaptic plasticity in various brain regions, including the hippocampus, amygdala, striatum, cerebral cortex, and cerebellum. There appear to be mechanisms that limit the excitatory effects of the NO-cGMP system, such as inhibition of NMDA receptor responses or enhancing the release of GABA. NO participates in a wide range of physiological activities, ranging from regulation of blood pressure to processes underlying some forms of learning and memory. NO is not a specific marker of disease, because its widespread role in cell metabolism could suggest its involvement in many disorders. The wide spectrum of NO-associated psychiatric disorders includes neurodegenerative diseases, such as Alzheimer’s disease, as well as schizophrenia and mood and eating disorders. Agents intended to intervene in the NO pathway may provide a new approach to the treatment of certain neuropsychiatric disorders, including schizophrenia, mood and eating disorders, and neurodegenerative diseases.

목차

등록된 정보가 없습니다.

참고문헌 (27)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0